What is the recommended duration for using estrogen-based contraceptives, such as Yaz (drospirenone and ethinyl estradiol) or NuvaRing (etonogestrel and ethinyl estradiol), and what are the associated benefits and risks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration and Benefits/Risks of Estrogen-Based Contraceptives

Estrogen-based contraceptives can be safely used throughout a woman's reproductive years until menopause, as they are completely reversible with no negative effect on long-term fertility. 1

Duration of Use

  • Estrogen-based contraceptives (including COCs like Yaz and NuvaRing) can be used safely by women of all ages throughout their reproductive years, with no maximum duration limit specified in current guidelines 1
  • These methods can be continued until menopause, at which point transition to hormone replacement therapy may be considered if indicated 2
  • Regular follow-up visits are not required for continued use, though women should be advised to return if they experience side effects or wish to change methods 1

Effectiveness

  • With typical use, approximately 9 out of 100 women become pregnant in the first year of using combined hormonal contraceptives 1
  • The NuvaRing has a comparable typical-use failure rate (9%) to other combined hormonal methods 1
  • Extended or continuous cycle regimens may increase contraceptive effectiveness, especially among women who frequently miss pills 1

Benefits of Estrogen-Based Contraceptives

Contraceptive Benefits

  • Highly effective pregnancy prevention when used correctly 3
  • Completely reversible method with no negative effect on long-term fertility 1
  • Various formulations and delivery methods (pills, patch, ring) to accommodate different preferences 1

Non-Contraceptive Benefits

  • Decreased menstrual cramping and blood loss 1
  • Improvement in acne and other skin conditions 3, 4
  • Treatment for premenstrual dysphoric disorder (PMDD) and moderate acne vulgaris (specific to drospirenone-containing formulations like Yaz) 5, 4
  • Significant protection against endometrial and ovarian cancers after more than 3 years of use 1
  • Reduction in bone loss 2
  • Protection against iron deficiency anemia, dysmenorrhea, and benign breast disease 2
  • Extended or continuous cycle options can help manage conditions exacerbated by hormonal fluctuations (migraines without aura, epilepsy, irritable bowel syndrome, certain psychiatric symptoms) 1

Risks and Side Effects

  • Common side effects include unscheduled spotting or bleeding (especially during the first 3-6 months of use) 1
  • The incidence of intermenstrual bleeding typically decreases rapidly after the first cycle 3
  • Other potential side effects include breast tenderness, headaches, and nausea 1
  • Extended or continuous-cycle regimens may be associated with more breakthrough bleeding and spotting than traditional regimens 6
  • Venous thromboembolism is a rare but serious risk, with an incidence of 3-9 per 10,000 woman-years 1
  • No increased risk of breast cancer has been demonstrated 1

Patient Education Points

Proper Use Instructions

  • Explain the specific regimen for the chosen method (21-24 days of hormonal pills followed by 4-7 hormone-free days for standard COCs, or continuous use options) 1
  • Provide clear instructions for what to do if pills are missed, patches detach, or rings are removed 1
  • For COCs, emphasize that:
    • If one pill is late (<24 hours), take it as soon as possible and continue the regimen 1
    • If one pill is missed (24-48 hours), take the most recent missed pill and use backup contraception for 7 days 1
    • If two or more pills are missed (≥48 hours), take the most recent missed pill, discard others, and use backup contraception for 7 days 1

Managing Side Effects

  • Counsel patients that irregular bleeding is common in the first 3-6 months and generally improves with continued use 1
  • For unscheduled spotting or bleeding with COCs, NSAIDs for 5-7 days may help manage symptoms 1
  • For extended or continuous regimens with heavy bleeding, a hormone-free interval of 3-4 days may be considered 1
  • Advise patients about what to do if vomiting or severe diarrhea occurs while using COCs 1

When to Seek Medical Attention

  • Instruct patients to return if they experience concerning side effects or wish to change methods 1
  • Educate about warning signs that require immediate medical attention (severe headache, chest pain, severe leg pain, shortness of breath) 1
  • Explain when emergency contraception might be needed if pills are missed or other issues with method use occur 1

Long-term Considerations

  • Reassure patients about the safety of long-term use and reversibility of these methods 1
  • Discuss the cancer-protective benefits of longer duration of use (>3 years) 1
  • Consider discussing transition to other methods if appropriate based on age, risk factors, or changing needs 2

Special Considerations

  • For perimenopausal women, low-dose oral contraceptives can provide both contraception and management of perimenopausal symptoms 2
  • Extended or continuous cycle regimens may be particularly appropriate for women with medical conditions like anemia, severe dysmenorrhea, endometriosis, or bleeding disorders 1
  • Women who frequently miss pills should consider alternative methods that are less user-dependent (IUD, implant, injectable) 1
  • Drospirenone-containing pills (like Yaz) have unique antimineralocorticoid and antiandrogenic properties that may benefit women with certain conditions 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral contraceptive use during the perimenopausal years.

American family physician, 1998

Research

Drospirenone/ethinyl estradiol.

Drugs of today (Barcelona, Spain : 1998), 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.